ANTE
发表于 2025-3-23 12:08:22
http://reply.papertrans.cn/67/6626/662534/662534_11.png
灵敏
发表于 2025-3-23 14:40:11
http://reply.papertrans.cn/67/6626/662534/662534_12.png
大范围流行
发表于 2025-3-23 18:58:58
http://reply.papertrans.cn/67/6626/662534/662534_13.png
dry-eye
发表于 2025-3-23 22:26:09
http://reply.papertrans.cn/67/6626/662534/662534_14.png
curettage
发表于 2025-3-24 02:28:55
Clinical Cases Debate: Neoadjuvant Versus Adjuvant Immunotherapy in Localized Renal Cell Carcinoma (nt therapies have been successfully downstaged and are thereby amenable to surgical intervention, this has not yet become the standard of care. In the adjuvant setting, despite FDA approval for sunitinib as well as potentially beneficial outcomes in selected cohorts, the use of adjuvant vascular end
incite
发表于 2025-3-24 09:02:04
http://reply.papertrans.cn/67/6626/662534/662534_16.png
脆弱么
发表于 2025-3-24 12:34:02
Book 2022 an overview of biomarker use for patient selection across the early-stage GU malignancies. Lastly, the book provides the reader with the most up-to-date data emerging from clinical trials involving immunotherapy in early-stage GU malignancies. .Neoadjuvant Immunotherapy Treatment of Localized Genit
毗邻
发表于 2025-3-24 17:16:43
Neoadjuvant Immunotherapy Treatment of Localized Genitourinary CancersMultidisciplinary Ma
CESS
发表于 2025-3-24 22:17:10
Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers978-3-030-80546-3
谷物
发表于 2025-3-24 23:35:09
http://reply.papertrans.cn/67/6626/662534/662534_20.png